APO Research

APO RESEARCH · REPORT

Bacillary Dysentery Drug

Selected research

Industry Growth & Trends

Global Bacillary Dysentery Drug Industry Growth and Trends Forecast to 2032

Market perspective

The global Bacillary Dysentery Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Bacillary Dysentery Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Bacillary Dysentery Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bacillary Dysentery Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bacillary Dysentery Drug include Akthelia Pharmaceuticals Ltd, GlaxoSmithKline Plc, Immuron Ltd, Microbiotix Inc and Protein Potential LLC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Bacillary Dysentery Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Bacillary Dysentery Drug market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bacillary Dysentery Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bacillary Dysentery Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Bacillary Dysentery Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Bacillary Dysentery Drug Market by Company

Akthelia Pharmaceuticals Ltd

GlaxoSmithKline Plc

Immuron Ltd

Microbiotix Inc

Protein Potential LLC

Bacillary Dysentery Drug Segment by Type

GVXNSD-133

KKL-35

SC-599

SF2a-TT15

Others

Bacillary Dysentery Drug Segment by Application

Clinic

Hospital

Others

Bacillary Dysentery Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bacillary Dysentery Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bacillary Dysentery Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bacillary Dysentery Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bacillary Dysentery Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Bacillary Dysentery Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of GVXNSD-133 Table 2. Major Company of KKL-35 Table 3. Major Company of SC-599 Table 4. Major Company of SF2a-TT15 Table 5. Major Company of Others Table 6. Global Bacillary Dysentery Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Bacillary Dysentery Drug Sales by Type (2021-2026) & (W Units) Table 8. Global Bacillary Dysentery Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global Bacillary Dysentery Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global Bacillary Dysentery Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global Bacillary Dysentery Drug Price by Type (2021-2026) & (US$/Unit) Table 12. Global Bacillary Dysentery Drug Sales by Type (2027-2032) & (W Units) Table 13. Global Bacillary Dysentery Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global Bacillary Dysentery Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global Bacillary Dysentery Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global Bacillary Dysentery Drug Price by Type (2027-2032) & (US$/Unit) Table 17. North America Bacillary Dysentery Drug Sales by Type (2021-2026) & (W Units) Table 18. North America Bacillary Dysentery Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Bacillary Dysentery Drug Sales by Type (2021-2026) & (W Units) Table 20. Europe Bacillary Dysentery Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Bacillary Dysentery Drug Sales by Type (2021-2026) & (W Units) Table 22. Asia-Pacific Bacillary Dysentery Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Bacillary Dysentery Drug Sales by Type (2021-2026) & (W Units) Table 24. Latin America Bacillary Dysentery Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Bacillary Dysentery Drug Sales by Type (2021-2026) & (W Units) Table 26. Middle East and Africa Bacillary Dysentery Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Bacillary Dysentery Drug Industry Trends Table 28. Bacillary Dysentery Drug Industry Drivers Table 29. Bacillary Dysentery Drug Industry Opportunities and Challenges Table 30. Bacillary Dysentery Drug Industry Restraints Table 31. Global Bacillary Dysentery Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Bacillary Dysentery Drug Revenue Market Share by Company (2021-2026) Table 33. Global Bacillary Dysentery Drug Sales by Company (2021-2026) & (W Units) Table 34. Global Bacillary Dysentery Drug Sales Share by Company (2021-2026) Table 35. Global Bacillary Dysentery Drug Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Bacillary Dysentery Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Bacillary Dysentery Drug Major Company Production Sites and Headquarters Table 38. Global Bacillary Dysentery Drug Company, Product Type & Application Table 39. Global Bacillary Dysentery Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Bacillary Dysentery Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Bacillary Dysentery Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Bacillary Dysentery Drug Sales by Region (2021-2026) & (W Units) Table 44. Global Bacillary Dysentery Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global Bacillary Dysentery Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global Bacillary Dysentery Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global Bacillary Dysentery Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Bacillary Dysentery Drug Sales by Region (2027-2032) & (W Units) Table 49. Global Bacillary Dysentery Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global Bacillary Dysentery Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global Bacillary Dysentery Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global Bacillary Dysentery Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Bacillary Dysentery Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Bacillary Dysentery Drug Sales by Application (2021-2026) & (W Units) Table 55. Global Bacillary Dysentery Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global Bacillary Dysentery Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global Bacillary Dysentery Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global Bacillary Dysentery Drug Price by Application (2021-2026) & (US$/Unit) Table 59. Global Bacillary Dysentery Drug Sales by Application (2027-2032) & (W Units) Table 60. Global Bacillary Dysentery Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global Bacillary Dysentery Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global Bacillary Dysentery Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global Bacillary Dysentery Drug Price by Application (2027-2032) & (US$/Unit) Table 64. North America Bacillary Dysentery Drug Sales by Application (2021-2026) & (W Units) Table 65. North America Bacillary Dysentery Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Bacillary Dysentery Drug Sales by Application (2021-2026) & (W Units) Table 67. Europe Bacillary Dysentery Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Bacillary Dysentery Drug Sales by Application (2021-2026) & (W Units) Table 69. Asia-Pacific Bacillary Dysentery Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Bacillary Dysentery Drug Sales by Application (2021-2026) & (W Units) Table 71. Latin America Bacillary Dysentery Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Bacillary Dysentery Drug Sales by Application (2021-2026) & (W Units) Table 73. Middle East and Africa Bacillary Dysentery Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Akthelia Pharmaceuticals Ltd Company Information Table 75. Akthelia Pharmaceuticals Ltd Business Overview Table 76. Akthelia Pharmaceuticals Ltd Bacillary Dysentery Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Akthelia Pharmaceuticals Ltd Bacillary Dysentery Drug Product Portfolio Table 78. Akthelia Pharmaceuticals Ltd Recent Development Table 79. GlaxoSmithKline Plc Company Information Table 80. GlaxoSmithKline Plc Business Overview Table 81. GlaxoSmithKline Plc Bacillary Dysentery Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. GlaxoSmithKline Plc Bacillary Dysentery Drug Product Portfolio Table 83. GlaxoSmithKline Plc Recent Development Table 84. Immuron Ltd Company Information Table 85. Immuron Ltd Business Overview Table 86. Immuron Ltd Bacillary Dysentery Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Immuron Ltd Bacillary Dysentery Drug Product Portfolio Table 88. Immuron Ltd Recent Development Table 89. Microbiotix Inc Company Information Table 90. Microbiotix Inc Business Overview Table 91. Microbiotix Inc Bacillary Dysentery Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Microbiotix Inc Bacillary Dysentery Drug Product Portfolio Table 93. Microbiotix Inc Recent Development Table 94. Protein Potential LLC Company Information Table 95. Protein Potential LLC Business Overview Table 96. Protein Potential LLC Bacillary Dysentery Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Protein Potential LLC Bacillary Dysentery Drug Product Portfolio Table 98. Protein Potential LLC Recent Development Table 99. North America Bacillary Dysentery Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 100. North America Bacillary Dysentery Drug Sales by Country (2021-2026) & (W Units) Table 101. North America Bacillary Dysentery Drug Sales Market Share by Country (2021-2026) Table 102. North America Bacillary Dysentery Drug Sales Forecast by Country (2027-2032) & (W Units) Table 103. North America Bacillary Dysentery Drug Sales Market Share Forecast by Country (2027-2032) Table 104. North America Bacillary Dysentery Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 105. North America Bacillary Dysentery Drug Market Size by Country (2021-2026) & (US$ Million) Table 106. North America Bacillary Dysentery Drug Market Share by Country (2021-2026) Table 107. North America Bacillary Dysentery Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 108. North America Bacillary Dysentery Drug Market Share Forecast by Country (2027-2032) Table 109. Europe Bacillary Dysentery Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 110. Europe Bacillary Dysentery Drug Sales by Country (2021-2026) & (W Units) Table 111. Europe Bacillary Dysentery Drug Sales Market Share by Country (2021-2026) Table 112. Europe Bacillary Dysentery Drug Sales Forecast by Country (2027-2032) & (W Units) Table 113. Europe Bacillary Dysentery Drug Sales Market Share Forecast by Country (2027-2032) Table 114. Europe Bacillary Dysentery Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. Europe Bacillary Dysentery Drug Market Size by Country (2021-2026) & (US$ Million) Table 116. Europe Bacillary Dysentery Drug Market Share by Country (2021-2026) Table 117. Europe Bacillary Dysentery Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. Europe Bacillary Dysentery Drug Market Share Forecast by Country (2027-2032) Table 119. Asia-Pacific Bacillary Dysentery Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 120. Asia-Pacific Bacillary Dysentery Drug Sales by Country (2021-2026) & (W Units) Table 121. Asia-Pacific Bacillary Dysentery Drug Sales Market Share by Country (2021-2026) Table 122. Asia-Pacific Bacillary Dysentery Drug Sales Forecast by Country (2027-2032) & (W Units) Table 123. Asia-Pacific Bacillary Dysentery Drug Sales Market Share Forecast by Country (2027-2032) Table 124. Asia-Pacific Bacillary Dysentery Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Asia-Pacific Bacillary Dysentery Drug Market Size by Country (2021-2026) & (US$ Million) Table 126. Asia-Pacific Bacillary Dysentery Drug Market Share by Country (2021-2026) Table 127. Asia-Pacific Bacillary Dysentery Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Asia-Pacific Bacillary Dysentery Drug Market Share Forecast by Country (2027-2032) Table 129. Latin America Bacillary Dysentery Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 130. Latin America Bacillary Dysentery Drug Sales by Country (2021-2026) & (W Units) Table 131. Latin America Bacillary Dysentery Drug Sales Market Share by Country (2021-2026) Table 132. Latin America Bacillary Dysentery Drug Sales Forecast by Country (2027-2032) & (W Units) Table 133. Latin America Bacillary Dysentery Drug Sales Market Share Forecast by Country (2027-2032) Table 134. Latin America Bacillary Dysentery Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Latin America Bacillary Dysentery Drug Market Size by Country (2021-2026) & (US$ Million) Table 136. Latin America Bacillary Dysentery Drug Market Share by Country (2021-2026) Table 137. Latin America Bacillary Dysentery Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Latin America Bacillary Dysentery Drug Market Share Forecast by Country (2027-2032) Table 139. Middle East and Africa Bacillary Dysentery Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 140. Middle East and Africa Bacillary Dysentery Drug Sales by Country (2021-2026) & (W Units) Table 141. Middle East and Africa Bacillary Dysentery Drug Sales Market Share by Country (2021-2026) Table 142. Middle East and Africa Bacillary Dysentery Drug Sales Forecast by Country (2027-2032) & (W Units) Table 143. Middle East and Africa Bacillary Dysentery Drug Sales Market Share Forecast by Country (2027-2032) Table 144. Middle East and Africa Bacillary Dysentery Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Middle East and Africa Bacillary Dysentery Drug Market Size by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa Bacillary Dysentery Drug Market Share by Country (2021-2026) Table 147. Middle East and Africa Bacillary Dysentery Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Middle East and Africa Bacillary Dysentery Drug Market Share Forecast by Country (2027-2032) Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Bacillary Dysentery Drug Distributors List Table 152. Bacillary Dysentery Drug Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Bacillary Dysentery Drug Image Figure 2. Global Bacillary Dysentery Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bacillary Dysentery Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Bacillary Dysentery Drug Sales (2021-2032) & (W Units) Figure 5. GVXNSD-133 Image Figure 6. Global GVXNSD-133 Sales YoY Growth (2021-2032) & (W Units) Figure 7. KKL-35 Image Figure 8. Global KKL-35 Sales YoY Growth (2021-2032) & (W Units) Figure 9. SC-599 Image Figure 10. Global SC-599 Sales YoY Growth (2021-2032) & (W Units) Figure 11. SF2a-TT15 Image Figure 12. Global SF2a-TT15 Sales YoY Growth (2021-2032) & (W Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 15. Global Bacillary Dysentery Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Bacillary Dysentery Drug Market Share by Type 2025 VS 2032 Figure 17. North America Bacillary Dysentery Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America Bacillary Dysentery Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe Bacillary Dysentery Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe Bacillary Dysentery Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Bacillary Dysentery Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Bacillary Dysentery Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America Bacillary Dysentery Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Bacillary Dysentery Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Bacillary Dysentery Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Bacillary Dysentery Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Bacillary Dysentery Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (W Units) Figure 31. Hospital Image Figure 32. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 35. Global Bacillary Dysentery Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Bacillary Dysentery Drug Market Share by Application 2025 VS 2032 Figure 37. North America Bacillary Dysentery Drug Sales Market Share in Volume by Application in 2025 Figure 38. North America Bacillary Dysentery Drug Sales Market Share in Value by Application in 2025 Figure 39. Europe Bacillary Dysentery Drug Sales Market Share in Volume by Application in 2025 Figure 40. Europe Bacillary Dysentery Drug Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Bacillary Dysentery Drug Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Bacillary Dysentery Drug Sales Market Share in Value by Application in 2025 Figure 43. Latin America Bacillary Dysentery Drug Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Bacillary Dysentery Drug Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Bacillary Dysentery Drug Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Bacillary Dysentery Drug Sales Market Share in Value by Application in 2025 Figure 47. North America Bacillary Dysentery Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. North America Bacillary Dysentery Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Bacillary Dysentery Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Bacillary Dysentery Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Bacillary Dysentery Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Europe Bacillary Dysentery Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Bacillary Dysentery Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Bacillary Dysentery Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Bacillary Dysentery Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Asia-Pacific Bacillary Dysentery Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Bacillary Dysentery Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Bacillary Dysentery Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Bacillary Dysentery Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Latin America Bacillary Dysentery Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Bacillary Dysentery Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Bacillary Dysentery Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Bacillary Dysentery Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Middle East and Africa Bacillary Dysentery Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Bacillary Dysentery Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Bacillary Dysentery Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Bacillary Dysentery Drug Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Bacillary Dysentery Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • GVXNSD-133
  • KKL-35
  • SC-599
  • SF2a-TT15
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Akthelia Pharmaceuticals Ltd
  • GlaxoSmithKline Plc
  • Immuron Ltd
  • Microbiotix Inc
  • Protein Potential LLC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bacillary Dysentery Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Bacillary Dysentery Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Bacillary Dysentery Drug Market by Type
  6. 1.3.1 GVXNSD-133
  7. 1.3.2 KKL-35
  8. 1.3.3 SC-599
  9. 1.3.4 SF2a-TT15
  10. 1.3.5 Others
  11. 1.4 Global Bacillary Dysentery Drug Market Size by Type
  12. 1.4.1 Global Bacillary Dysentery Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Bacillary Dysentery Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Bacillary Dysentery Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Bacillary Dysentery Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Bacillary Dysentery Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Bacillary Dysentery Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Bacillary Dysentery Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Bacillary Dysentery Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Bacillary Dysentery Drug Industry Trends
  2. 2.2 Bacillary Dysentery Drug Industry Drivers
  3. 2.3 Bacillary Dysentery Drug Industry Opportunities and Challenges
  4. 2.4 Bacillary Dysentery Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Bacillary Dysentery Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Bacillary Dysentery Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Bacillary Dysentery Drug Price (2021-2026)
  4. 3.4 Global Bacillary Dysentery Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bacillary Dysentery Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Bacillary Dysentery Drug Company, Product Type & Application
  7. 3.7 Global Bacillary Dysentery Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bacillary Dysentery Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bacillary Dysentery Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bacillary Dysentery Drug Tier 1, Tier 2, and Tier 3
4 Bacillary Dysentery Drug Regional Status and Outlook
  1. 4.1 Global Bacillary Dysentery Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Bacillary Dysentery Drug Historic Market Size by Region
  3. 4.2.1 Global Bacillary Dysentery Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Bacillary Dysentery Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Bacillary Dysentery Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Bacillary Dysentery Drug Forecasted Market Size by Region
  7. 4.3.1 Global Bacillary Dysentery Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Bacillary Dysentery Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Bacillary Dysentery Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Bacillary Dysentery Drug by Application
  1. 5.1 Bacillary Dysentery Drug Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Bacillary Dysentery Drug Market Size by Application
  6. 5.2.1 Global Bacillary Dysentery Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Bacillary Dysentery Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Bacillary Dysentery Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Bacillary Dysentery Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Bacillary Dysentery Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Bacillary Dysentery Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Bacillary Dysentery Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Bacillary Dysentery Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Akthelia Pharmaceuticals Ltd
  2. 6.1.1 Akthelia Pharmaceuticals Ltd Company Information
  3. 6.1.2 Akthelia Pharmaceuticals Ltd Business Overview
  4. 6.1.3 Akthelia Pharmaceuticals Ltd Bacillary Dysentery Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Akthelia Pharmaceuticals Ltd Bacillary Dysentery Drug Product Portfolio
  6. 6.1.5 Akthelia Pharmaceuticals Ltd Recent Developments
  7. 6.2 GlaxoSmithKline Plc
  8. 6.2.1 GlaxoSmithKline Plc Company Information
  9. 6.2.2 GlaxoSmithKline Plc Business Overview
  10. 6.2.3 GlaxoSmithKline Plc Bacillary Dysentery Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GlaxoSmithKline Plc Bacillary Dysentery Drug Product Portfolio
  12. 6.2.5 GlaxoSmithKline Plc Recent Developments
  13. 6.3 Immuron Ltd
  14. 6.3.1 Immuron Ltd Company Information
  15. 6.3.2 Immuron Ltd Business Overview
  16. 6.3.3 Immuron Ltd Bacillary Dysentery Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Immuron Ltd Bacillary Dysentery Drug Product Portfolio
  18. 6.3.5 Immuron Ltd Recent Developments
  19. 6.4 Microbiotix Inc
  20. 6.4.1 Microbiotix Inc Company Information
  21. 6.4.2 Microbiotix Inc Business Overview
  22. 6.4.3 Microbiotix Inc Bacillary Dysentery Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Microbiotix Inc Bacillary Dysentery Drug Product Portfolio
  24. 6.4.5 Microbiotix Inc Recent Developments
  25. 6.5 Protein Potential LLC
  26. 6.5.1 Protein Potential LLC Company Information
  27. 6.5.2 Protein Potential LLC Business Overview
  28. 6.5.3 Protein Potential LLC Bacillary Dysentery Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Protein Potential LLC Bacillary Dysentery Drug Product Portfolio
  30. 6.5.5 Protein Potential LLC Recent Developments
7 North America by Country
  1. 7.1 North America Bacillary Dysentery Drug Sales by Country
  2. 7.1.1 North America Bacillary Dysentery Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Bacillary Dysentery Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Bacillary Dysentery Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Bacillary Dysentery Drug Market Size by Country
  6. 7.2.1 North America Bacillary Dysentery Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Bacillary Dysentery Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Bacillary Dysentery Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Bacillary Dysentery Drug Sales by Country
  2. 8.1.1 Europe Bacillary Dysentery Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Bacillary Dysentery Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Bacillary Dysentery Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Bacillary Dysentery Drug Market Size by Country
  6. 8.2.1 Europe Bacillary Dysentery Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Bacillary Dysentery Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Bacillary Dysentery Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Bacillary Dysentery Drug Sales by Country
  2. 9.1.1 Asia-Pacific Bacillary Dysentery Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Bacillary Dysentery Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Bacillary Dysentery Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Bacillary Dysentery Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Bacillary Dysentery Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Bacillary Dysentery Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Bacillary Dysentery Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Bacillary Dysentery Drug Sales by Country
  2. 10.1.1 South America Bacillary Dysentery Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Bacillary Dysentery Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Bacillary Dysentery Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Bacillary Dysentery Drug Market Size by Country
  6. 10.2.1 South America Bacillary Dysentery Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Bacillary Dysentery Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Bacillary Dysentery Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Bacillary Dysentery Drug Sales by Country
  2. 11.1.1 Middle East and Africa Bacillary Dysentery Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Bacillary Dysentery Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Bacillary Dysentery Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Bacillary Dysentery Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Bacillary Dysentery Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Bacillary Dysentery Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Bacillary Dysentery Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Bacillary Dysentery Drug Value Chain Analysis
  2. 12.1.1 Bacillary Dysentery Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Bacillary Dysentery Drug Production Mode & Process
  7. 12.2 Bacillary Dysentery Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Bacillary Dysentery Drug Distributors
  10. 12.2.3 Bacillary Dysentery Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research